SBIR/STTR Research Award

ORGANIC LIGANDS THAT ALTER PARATHYROID CELL FUNCTION

Award identifier 2be433da93c39bd676f5090fea892e26a55ce68eb6cfc57c8adc9dd326d8fae4Awarding agency Department of Health and Human Services

Award amount

$498,186

Program and phase

SBIR · Phase II

Award year

1992

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Natural Products Research,
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

RECENT STUDIES HAVE PROVIDED EVIDENCE FOR THE PRESENCE OF A CA(2+) RECEPTOR ON THE SURFACE OF PARATHYROID CELLS THAT ENABLES THESE CELLS TO DETECT SMALL CHANGES IN THE CONCENTRATION OF EXTRACELLULAR CA(2+) AND THEREBY ALTER PARATHYROID HORMONE (PTH) SECRETION. THIS CA(2+) RECEPTOR IS COUPLED TO THE MOBILIZATION OF INTRACELLULAR CA(2+) AND SHOWS MANY OF THE BIOCHEMICAL FEATURES COMMON TO MORE CONVENTIONAL CA(2+)-MOBILIZING RECEPTORS. THE ONLY AGENTS KNOWN TO ACT AT THE CA(2+) RECEPTOR ARE DI- AND TRIVALENT METAL CATIONS. THIS RESEARCH WILL EXAMINETHE POSSIBILITY THAT CERTAIN ORGANIC COMPOUNDS MIGHT BEHAVE SIMILARLY TO EXTRACELLULAR CA(2+) AND REGULATE PTH SECRETION BY ACTING AS LIGANDS AT THE CA(2+) RECEPTOR. ORGANIC POLYCATIONS (MOST NOTABLY SPERMINE) WILL BE EXAMINEDFOR THEIR ABILITY, USING BOVINE AND HUMAN PARATHYROID CELLS,TO 91) MOBILIZE INTRACELLULAR CA(2+), (2) INCREASE INOSITOL PHOSPHATE FORMATION, (3) DECREASE CYCLIC AMP FORMATION, AND (4) INHIBIT PTH SECRETION. COMPARISONS OF THESE RESULTS WILL BE MADE WITH THOSE OBTAINED WITH EXTRACELLULAR CA(2+) TO DETERMINE IF BOTH ORGANIC AND INORGANIC AGENTS ACT THROUGH THE SAME RECEPTOR-DEPENDENT MECHANISM. ORGANIC COMPOUNDS ACTING SIMILARLY TO EXTRACELLULAR CA(2+) MIGHT THEN PROVIDE LEAD STRUCTURES FOR THE DEVELOPMENT OF NOVEL THERAPEUTICS EFFECTIVE IN THE TREATMENT OF VARIOUS BONE AND MINERAL-RELATED DISORDERS SUCH AS HYPERPARATHYROIDISM AND OSTEOPOROSIS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.